The Insides System for managing intestinal failure (MIB286)
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure
Search results
8 results for ibd
-
-
Immunoscore for predicting risk of colon cancer relapse (MIB269)
NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse
-
eXroid for internal haemorrhoids (MIB201)
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
-
PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)
We have temporarily withdrawn this medtech innovation briefing to update the information with regard to further research in this area.
-
Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)
NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory
-
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
-
Ulcerative colitis: budesonide multimatrix (Cortiment) (ESNM58)
Summary of the evidence on budesonide multimatrix (Cortiment) for treating ulcerative colitis (UC) to inform local NHS planning and decision-making
-
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection